Tokyo, March 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060984) titled 'Observational Study on Support for Treatment-Work Balance among Patients with Cardiovascular Diseases in Shimane University Hospital' on March 19.

Study Type: Observational

Primary Sponsor: Institute - Shimane University Faculty of Medicine

Condition: Condition - Cardiovascular Diseases Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To identify the current status of comprehensive support for balancing treatment and work provided to patients with cardiovascular disease. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old =18 years at the time of obtaining informed consent (regardless of sex). 2) Patients admitted to the Department of Cardiovascular Medicine at Shimane University Hospital for evaluation and treatment of acute coronary syndrome, acute heart failure, valvular heart disease, arrhythmia, or cardiomyopathy. 3) Patients who were engaged in some form of employment prior to admission (including full-time employment, part-time/non-regular employment, or self-employment), or who express a desire to work after discharge. 4) Patients who, after receiving a full explanation of the study and demonstrating sufficient understanding, provide written informed consent of their own free will to participate in this study. Key exclusion criteria - 1) Patients admitted solely for planned treatments (e.g., elective PCI, ablation, TAVI, MitraClip) or for diagnostic evaluation. 2)Patients in whom continuation of employment is considered medically difficult due to severe comorbidities, progressive malignancy, end-stage renal failure, or similar conditions. 3) Patients for whom completion of questionnaires or follow-up is difficult due to advanced dementia or severe psychiatric disorders. 4) Patients whom the attending physician judges to have a life expectancy of less than 6 months at the time of study enrollment. 5) Patients expected to relocate overseas, be lost to follow-up (e.g., unknown contact information), or require prolonged hospitalization. 6) Patients deemed inappropriate for participation in this study by the attending physician or the principal investigator for any other reason. Target Size - 50

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 03 Month 20 Day Anticipated trial start date - 2026 Year 03 Month 23 Day Last follow-up date - 2029 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069784

Disclaimer: Curated by HT Syndication.